Warehouse Stock Clearance Sale

Grab a bargain today!

  1. Search
  2. All Products
Refine By
Category
Industries (2)
Operations (1)
Sold By
All Sellers
Fishpond (3)
Country
All Countries
United States (3)
    Results for "Benjamin Bonavida"
    Benjamin Bonavida
    4 results
    Refine By
    Category
    Industries (2)
    Operations (1)
    Sold By
    All Sellers
    Fishpond (3)
    Country
    All Countries
    United States (3)
      4 results
      • Bestselling
      • Relevance
      • Price: Lowest
      Sort By
      View:
      Overcoming Cancers Resistant­ to HER-2 Antibodies (Breaking Tolerance to Antibody-Mediated Immunotherapy)
      By Benjamin Bonavida
      Overcoming Cancers Resistant­ to HER-2 Antibodies (Breaking Tolerance to Antibody-Mediated Immunotherapy)
      By Benjamin Bonavida
      £98.51 Elsewhere £115.00 Save £16.49 (14%)
      Targeting Cell Survival ­Pathways to Enhance ­Response to Chemotherapy, ­Volume 3 (Cancer Sensitizing Agents for Chemotherapy)
      By Benjamin Bonavida, Daniel E. Johnson
      Targeting Cell Survival ­Pathways to Enhance ­Response to Chemotherapy, ­Volume 3 (Cancer Sensitizing Agents for Chemotherapy)
      By Benjamin Bonavida, Daniel E. Johnson
      £114 Elsewhere £135.00 Save £21.00 (16%)
      Therapeutic Applications of ­Nitric Oxide in Cancer and­ Inflammatory Disorders (Third International Conference on Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders)
      By Valentina Rapozzi, Luigi Xodo, Benjamin Bonavida
      Therapeutic Applications of ­Nitric Oxide in Cancer and­ Inflammatory Disorders (Third International Conference on Therapeutic Application of Nitric Oxide in Cancer and Inflammatory Disorders)
      By Valentina Rapozzi, Luigi Xodo, Benjamin Bonavida
      £120 Elsewhere £142.00 Save £22.00 (15%)
      New Combination Approaches ­to Enhance Rituximab-Based ­Lymphoma Therapies (Breaking Tolerance to Antibody-Mediated Immunotherapy)
      By Benjamin Bonavida
      New Combination Approaches ­to Enhance Rituximab-Based ­Lymphoma Therapies (Breaking Tolerance to Antibody-Mediated Immunotherapy)
      By Benjamin Bonavida
      Currently
      Unavailable
      We use essential and some optional cookies to provide you the best shopping experience. Visit our cookies policy page for more information.